# K170726: Biopsy Forceps

- Pathway: 510(k) (Traditional)
- Applicant: Fehling Instruments GmbH & Co. KG
- Decided: Jun 2, 2017 after 85 days
- Product code: DWZ (Device, Biopsy, Endomyocardial)
- Device class: 2
- Regulation: 21 CFR 870.4075
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K870186 (1987). 3 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 5 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K973818: T-Rex Biopsy Forceps, Boston Scientific Corp (1997) Summary page 5.
- K881412: Myocard Biopsy Forcep, Fehling Medizintechnik GmbH (1988) Summary page 5.

## Most influential descendants
- K252722: Biopsy Forceps (2025), 0 descendants of its own

## Indications for use
FEHLING biopsy forceps are used to obtain endomyocardial biopsy specimens from the right and left ventricle via percutaneous arterial or venous approach.

Source page: https://510kreport.com/device/K170726
Methodology: https://510kreport.com/methodology